Development of a new immunochemistry method using antibodies of proteins related pancreatic cancer in the pancreatic cancer cell
Not Applicable
- Conditions
- Neoplasms
- Registration Number
- KCT0006134
- Lead Sponsor
- Yonsei University Health System, Gangnam Severance Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
1. Patients with pancreatic cancer confirmed by imaging (CT, MRI, PET-CT)
2. Patients with pancreatic cancer diagnosed using cytology by endoscopic ultrasound
3. Patients who underwent surgical treatment with pancreatic cancer
Exclusion Criteria
1. Minors under the age of 19, vulnerable subjects such as illiteracy
2. Excludes necrotic specimens
Study & Design
- Study Type
- Observational Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Compare the results of immunofluorescence staining and immunochemical staining according to the type of brush cell slide (thinprep, surepath, direct smear) to confirm the correlation with the final diagnosis name. (With a correlation of 80% or more, the optimal staining method with the highest correlation is identified.)
- Secondary Outcome Measures
Name Time Method Efficacy of staining method(the sensitivity, specificity, accuracy, positive predictive value and negative predictive value)